Promote cooperation and seek common development. On May 21, the bank enterprise exchange Symposium of Hunan biomedical industry was held in Shanghai Pudong Development Bank Co.Ltd(600000) financial building. At the meeting, Hunan Pharmaceutical Industry Association signed a strategic cooperation agreement with Shanghai Pudong Development Bank Co.Ltd(600000) Changsha branch. According to the agreement, Shanghai Pudong Development Bank Co.Ltd(600000) Changsha branch will provide a comprehensive financing line of 8 billion yuan for the pharmaceutical industry in the next three years, mainly serving credit extension, bond investment, domestic and foreign mergers and acquisitions and other fields.
With the theme of “development prospect of Hunan biomedical industry in the post epidemic era”, this symposium aims to gather the joint efforts of the government, associations, enterprises, banks, securities companies and venture capital companies to promote the high-quality development of the pharmaceutical industry in the province. Hunan Provincial Department of industry and information technology, Hunan Pharmaceutical Industry Association and representatives of several biomedical industries participated in the discussion.
During the event, Xie Zilong, chairman of Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy, reviewed the development process of win-win cooperation with Shanghai Pudong Development Bank Co.Ltd(600000) Changsha branch. Fu Siyou, director of Bank Research of sanze Research Institute, gave a thematic report on “investment and financing trends and development opportunities of biomedical industry in the post epidemic era”. Shanghai Pudong Development Bank Co.Ltd(600000) experts also shared “investment banking services under the investment and financing needs of biomedical industry” and “family trust wealth inheritance” with the guests.
“Today’s Symposium between banks and enterprises is a breakthrough in the pharmaceutical industry.” Huang Baolin, deputy director of Hunan Provincial Department of industry and information technology, introduced that the pharmaceutical industry in Hunan Province maintained a rapid growth rate. In 2021, the pharmaceutical industry above Designated Size completed a main business income of 125.2 billion yuan, a year-on-year increase of 7.5%. He said that by building a communication platform between banks and enterprises, further deepening bank enterprise cooperation and forming a good situation of “Trinity” of departments, banks and enterprises, it is of great significance to accelerate the sustainable and healthy development of the pharmaceutical industry in the province.
Mr. Wang Geng, President of Changsha branch, shared with the guests who had participated in the practice of biological medicine industry for many years. He introduced that Shanghai Pudong Development Bank Co.Ltd(600000) Changsha branch has deeply focused on the whole industrial chain of biomedicine and provided comprehensive, professional and field oriented financial services for more than 400 enterprises in seven sectors, including medical institutions, pharmaceutical manufacturing, medical devices, bioengineering, retail pharmacies, commercial wholesale and medical big health data, including more than 50 credit support customers with a credit amount of more than 7 billion yuan. At the same time, it has also achieved good demonstration and guidance in Aier Eye Hospital Group Co.Ltd(300015) overseas M & A, Lbx Pharmacy Chain Joint Stock Company(603883) domestic M & A of Yifeng pharmacy, construction of Hunan Women’s and children’s Hospital, Aier Eye Hospital Group Co.Ltd(300015) partner plan, offshore direct loan and other projects.
“In the future, we will continue to practice the business strategy of ‘Commercial Bank + investment bank, financing + intelligence integration and equity debt loan integration’, deeply cultivate the biomedical industry, actively explore the depth and breadth of the integration of production and finance, innovate financial products, increase financial support, and fully support the expansion and strengthening of Hunan biomedical industry.” Wang Qi said.
\u3000\u3000
